-
Antibody production
What are chimeric antibodies?
Considered by many researchers as intermediate molecules, chimeric antibody constructs have been gradually losing ground to more effective molecules such as humanized and human antibodies. Today, these structural chimeras represent…
-
Antibody production
How are mouse monoclonal antibodies humanized: current approaches and limitations
Read more -
Antibody production
The best CHO expression system kits on the market
Read more -
Blog
Humanized vs. Fully Human Antibodies: What’s the Difference?
Read more -
Antibody production
How Can Single B Cell Sorting Propel Your Antibody Discovery to New Heights?
Read more -
Antibody production
The Evolution of Antibody Production
Read more
-
Blog
Which approach should you choose to get a species-specific veterinary monoclonal antibody? A decision guide
Read more -
Customers success stories
Next-Generation Antibody Discovery Enabled By NativeMP™ and Phage Display Technology
Read more -
Customers success stories
Accelerating Translational Research: How Phage Display Technology Delivered High-Affinity Antibodies for Groundbreaking Applications
Read more -
Blog
Humanized vs. Fully Human Antibodies: What’s the Difference?
Read more -
Customers success stories
The Path of Creating an Innovative IL-17A Antibody for Autoimmune Disorders
Read more
-
Antibody production
“The COVID-19 pandemic is helping us bridge the divide between virologists and immunologists” – Interview with Dr. Louisa James (QMUL)
Read more -
Antibody production
Reinventing IgY biotherapeutics – interview with Dr. Mara Freire (CICECO, University of Aveiro, Portugal)
Read more -
Antibody production
How the environment shapes immune system development during pregnancy – interview with Dr. Melanie Conrad
Read more -
Antibody production
“Cell-based phage display is helping us isolate more biologically relevant antibodies” – Interview with Dr. Mohamed Alfaleh (King Abdulaziz University)
Read more -
Antibody production
“Researchers are not leveraging the speed and resolution of flow cytometry for clinical evaluation” – Interview with Prof. Tomáš Kalina (Charles University in Prague)
Read more